PowerHome is a manufacturer and global supplier of power conversion equipment, specializing in single-phase and three-phase ...

Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...

PBGENE-DMD aims to deliver sustained muscle function improvement for DMD patients with mutations between exons 45 and 55.

TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist ...

Researchers used mass spectrometry to map the molecular composition of fetal bovine serum, identifying a core proteome ...

The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...

Pause of enrollment limited to US sites in ENIGMA-TRS 2; Global ENIGMA-TRS 1 study continues with over 400 patients enrolled. Ad hoc announcement pursuant to Art. 53 LR. MILAN & M ...

EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...

Denovo Biopharma, a pioneer in applying precision medicine in central nervous system (CNS) diseases, today announced that the U.S. Patent and Trademark Office issued U.S. patent number 12,612,261, ...

Confirmed RECIST v1.1 ORR favored varegacestat (56% vs 9%; P<.0001), with exploratory median best tumor-volume change of −83% ...

We put five of today's most powerful, flexible and versatile synth plugins to the test to find out who comes out on top ...